ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $5,000 | -28.6% | 2,180 | 0.0% | 0.00% | – |
Q2 2020 | $7,000 | +40.0% | 2,180 | 0.0% | 0.00% | – |
Q1 2020 | $5,000 | 0.0% | 2,180 | +87.9% | 0.00% | – |
Q4 2019 | $5,000 | 0.0% | 1,160 | 0.0% | 0.00% | – |
Q3 2019 | $5,000 | -28.6% | 1,160 | 0.0% | 0.00% | – |
Q2 2019 | $7,000 | +75.0% | 1,160 | 0.0% | 0.00% | – |
Q1 2019 | $4,000 | +100.0% | 1,160 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -50.0% | 1,160 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 1,160 | -22.1% | 0.00% | – |
Q2 2018 | $4,000 | -33.3% | 1,490 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | 0.0% | 1,490 | 0.0% | 0.00% | – |
Q4 2017 | $6,000 | -33.3% | 1,490 | 0.0% | 0.00% | – |
Q3 2017 | $9,000 | 0.0% | 1,490 | 0.0% | 0.00% | – |
Q2 2017 | $9,000 | 0.0% | 1,490 | 0.0% | 0.00% | – |
Q1 2017 | $9,000 | -40.0% | 1,490 | -46.7% | 0.00% | – |
Q4 2016 | $15,000 | -6.2% | 2,797 | 0.0% | 0.00% | – |
Q3 2016 | $16,000 | +100.0% | 2,797 | +100.2% | 0.00% | – |
Q2 2016 | $8,000 | -20.0% | 1,397 | 0.0% | 0.00% | – |
Q1 2016 | $10,000 | – | 1,397 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |